Cyprus will start the voluntary COVID-19 vaccination of children over 12 next week using mRNA shots produced by Pfizer/BioNTech and Moderna
NICOSIA, Cyprus — Cyprus will start the voluntary COVID-19 vaccination of children over age 12 next week using mRNA shots produced by Pfizer/BioNTech and Moderna, authorities said Friday.
The consent of parents and guardians is a prerequisite for all children’s vaccinations in Cyprus. Hadjipantela urged young people to get the shot, with officials saying the median age of those infected in the last 14 days is 28.
“The world’s scientific community is in unison making it loud and clear that those who haven’t been vaccinated yet are most at risk,” Hadjipantela told reporters.
But some critics say that vaccinating children and younger populations in richer countries leads to inequity in developing nations, which have struggled to secure enough doses to inoculate even their most vulnerable populations.
Hadjipantela also announced that the compulsory display of the “SafePass” — electronic or paper documentation proving either vaccination, having been infected in the last six months or indicating a negative PCR test in the previous 72 hours — will be expanded. Apart from all indoor and outdoor restaurant, bar and club areas as well as shopping malls and other retail stores, “SafePass” must now be displayed at nursing homes and hospitals.
The “SafePass” measure has triggered a wave of disenchantment among those who say this is another assault on their right to assemble and go wherever they please.
Meanwhile, foreigners traveling to Cyprus must undergo a PCR test a week into their stay. Only travelers who have been vaccinated or recovered from COVID-19 in the previous three months are exempt.
Cyprus in the last month has seen COVID-19 infections spike to their highest levels since the start of the pandemic. More than 98,000 people have so far been infected with COVID-19, corresponding to more than 10% of the east Mediterranean island nation’s population.
Follow AP’s pandemic coverage at: